| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |